The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita AlaggioPathology Unit, Department of Laboratories, Bambino Gesu Children's Hospital, IRCCS, Rome, ItalyCatalina AmadorDepartment of Pathology, University of Miami, Miami, FL, USAIoannis AnagnostopoulosInstitute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyAyoma D. AttygalleDepartment of Histopathology, Royal Marsden Hospital, London, UKIguaracyra AraújoDepartment of Pathology, Federal University of Bahia (UFBA), Salvador, BrazilEmilio BertiUniversity of Milan, Fondazione Cà Granda, IRCCS, Ospedale Maggiore Policlinico, Milan, ItalyGovind BhagatDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USAAnita BorgesDivision of Histopathology, SL Raheja Hospital, Mumbai, IndiaDaniel F. BoyerDepartment of Pathology, University of Michigan, Ann Arbor, MI, USAMaria CalaminiciCentre for Haemato-Oncology, Barts Cancer institute, QMUL and SIHMDS Barts Health NHS Trust, London, UKAmy ChadburnWeill Cornell MedicineJohn K. C. ChanDepartment of Pathology, Queen Elizabeth Hospital, Kowloon, Hong KongWah CheukDepartment of Pathology, Queen Elizabeth Hospital, Kowloon, Hong KongWee Joo ChngNational University Cancer Institute, Singapore, SingaporeJohn ChoiDepartment of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USAShih‐Sung ChuangDepartment of Pathology, Chi-Mei Medical Center, Tainan, TaiwanSarah E. CouplandMagdalena CzaderDepartment of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN, USASandeep S. DavéCenter for Genomic and Computational Biology and Department of Medicine, Duke University, Durham, NC, USADaphne de JongAmsterdam UMC, location Vrije Universiteit Amsterdam, Department of Pathology, Amsterdam, The NetherlandsMing‐Qing DuDivision of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge, UK. [email protected]Kojo S.J. Elenitoba‐JohnsonDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USAJudith A. FerryDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. [email protected]Julia T. GeyerDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USADita GratzingerDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USAJoan GuitartDepartment. of Dermatology, Northwestern University Feinberg Medical School, Chicago, IL, USASumeet GujralDepartment of Pathology, Tata Memorial Hospital, Mumbai, IndiaMarian H. HarrisDepartment of Pathology, Boston Children's Hospital, Boston, MA, USAChristine J. HarrisonTranslational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, UKSylvia HartmannDr. Senckenberg Institute of Pathology, Goethe University Frankfurt, Frankfurt am Main, GermanyAndreas HochhausHematology/Oncology, Universitätsklinikum Jena, Jena, GermanyPatty M. JansenLeiden University Medical Center, Department of Pathology, Leiden, The NetherlandsKennosuke KarubeWerner KempfJoseph D. KhouryDepartment of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAHiroshi KimuraDepartment of Virology, Nagoya University Graduate School of Medicine, Nagoya, JapanWolfgang HiddemannDepartment of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, University of Kiel, Kiel, GermanyAlexandra E. KovachDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USAShaji KumarDivision of Hematology, Mayo Clinic, Rochester, MN, USAAlexander J. LazarDepartments of Pathology & Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAStefano LazziDepartment of Medical Biotechnology, University of Siena, Siena, ItalyLorenzo LeonciniDepartment of Medical Biotechnology, University of Siena, Siena, ItalyNelson LeungDivision of Nephrology and Hypertension, Division of Hematology, Mayo Clinic, Rochester, MN, USAVasiliki LeventakiDepartment of Pathology, Medical College of Wisconsin and Children's Wisconsin, Milwaukee, WI, USAXiao‐Qiu LiDepartment of Pathology, Fudan University Shanghai Cancer Center, Shanghai, ChinaMegan S. LimDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USAWeiping LiuDepartment of Pathology, West-China Hospital, Sichuan University, Chengdu, ChinaAbner LouissaintDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAAndrea N. MarcoglieseDepartment of Pathology & Immunology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USAL. Jeffrey MedeirosDepartment of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAMichael MichalDepartment of Pathology, Charles University in Prague, Faculty of Medicine in Plzen, Plzen, Czech RepublicRoberto N. MirandaDepartment of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAChristina MitteldorfDepartment of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, GermanySantiago Montes‐MorenoAnatomic Pathology Department and Translational Hematopathology Lab, Valdecilla/IDIVAL University Hospital, Santander, SpainWilliam G. MoriceDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAValentina NardiDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAKikkeri N. NareshSection of Pathology, Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USAYasodha NatkunamDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USASiok‐Bian NgDepartment of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SingaporeIlske OschliesDepartment of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, University of Kiel, Kiel, GermanyGerman OttDepartment of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany. [email protected]Marie ParrensDepartment of Pathology, Bordeaux University Hospital, Bordeaux, FranceMelissa PulitzerDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAS. Vincent RajkumarDivision of Hematology, Mayo Clinic, Rochester, Minnesota, Rochester, MN, USAAndy C. RawstronHMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UKKaren L. RechDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USAAndreas RosenwaldInstitute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, GermanyJonathan SaidDepartment of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, USAClémentine SarkozyMD-PhD, DITEP, Gustave Roussy, Villejuif, FranceShahin SayedDepartment of Pathology- Aga Khan University Hospital- Nairobi, Nairobi, KenyaCaner SayginSection of Hematology/Oncology, University of Chicago, Chicago, IL, USAAnna SchuhDepartment of Oncology, University of Oxford, Oxford, UKWilliam A. SewellImmunology Division, Garvan Institute of Medical Research, Sydney, AustraliaReiner SiebertInstitute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany. [email protected]Aliyah R. SohaniDepartment of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USAReuben ToozeDivision of Haematology and Immunology, Leeds Institute of Medical Research, University of Leeds, Leeds, UKAlexandra Traverse‐GlehenHospices Civils de Lyon/Department of Pathology/ Université Lyon 1/ Centre International de Recherche en Infectiologie (CIRI) INSERM U1111 -, CNRS UMR5308, Lyon, FranceFrancisco VegaDepartment of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAB. VergierDepartment of Pathology, Hopital Haut-Lévêque, CHU Bordeaux, Pessac, FranceAshutosh WechalekarNational Amyloidosis Centre, University College London, London, UKBrent L. WoodDepartment of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA, USALuc XerriDepartment of Pathology, Institut Paoli-Calmettes and Aix-Marseillreference University, Marseille, FranceWenbin XiaoDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
2022en
ABI
Аннотация
Abstract We herein present an overview of the upcoming 5 th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4 th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5 th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 3Использованных источников: 0